Kirsch, V.C.* ; Orgler, C.* ; Braig, S.* ; Jeremias, I. ; Auerbach, D.* ; Müller, R.* ; Vollmar, A.M.* ; Sieber, S.A.*
The cytotoxic natural product vioprolide A targets nucleolar protein 14 essential for ribosome biogenesis.
Angew. Chem.-Int. Edit. 59, 1595-1600 (2019)
Novel targets are needed for treatment of devastating diseases such as cancer. For decades, natural products have guided innovative therapies by addressing diverse pathways. Inspired by the potent cytotoxic bioactivity of myxobacterial vioprolides A-D, we performed in-depth studies on their mode of action. Based on its prominent potency against human acute lymphoblastic leukemia (ALL) cells, we conducted thermal proteome profiling (TPP) and deciphered the target proteins of the most active derivative vioprolide A (VioA) in Jurkat cells. Nucleolar protein 14 (NOP14), which is essential in ribosome biogenesis, was confirmed as a specific target of VioA by a suite of proteomic and biological follow-up experiments. Given its activity against ALL cells compared to healthy lymphocytes, VioA exhibits unique therapeutic potential for anticancer therapy through a novel mode of action.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Acute Lymphoblastic Leukemia ; Natural Products ; Quantitative Proteomics ; Ribosomess ; Target Identification; Computational Platform; Identification; Emg1
Keywords plus
Language
english
Publication Year
2019
Prepublished in Year
HGF-reported in Year
2019
ISSN (print) / ISBN
1433-7851
e-ISSN
1521-3773
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 59,
Issue: 4,
Pages: 1595-1600
Article Number: ,
Supplement: ,
Series
Publisher
Wiley
Publishing Place
Weinheim
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
Institute(s)
Research Unit Apoptosis in Hematopoietic Stem Cells (AHS)
POF-Topic(s)
30204 - Cell Programming and Repair
Research field(s)
Stem Cell and Neuroscience
PSP Element(s)
G-506600-001
Grants
Copyright
Erfassungsdatum
2019-12-23